Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients with lower vision, according to a speaker here. During a presentation at ...

The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.

This code is designed for detecting Diabetic Retinopathy in retinal fundus images using a deep learning approach. It preprocesses the images, applies data augmentation to improve model generalization, ...

Diabetic retinopathy is a common complication in people with type 1 and type 2 diabetes, progressing from mild, moderate, and ...

AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced updates to the ABBV-RGX-314 clinical program.

Global diabetic retinopathy market is anticipated to exhibit a CAGR of 6.43% during the forecast period 2024-2031 due to increasing prevalence of diabetes globally and rising demand for advanced ...

The U.S. market for exchange-listed equity option contracts was headed for another year of record-breaking trading volume in 2024 — its fifth in a row, according to data from the Options ...

incentive stock options and nonqualified stock options. That distinction has a big impact on the tax treatment, which in turn may affect the strategy you employ with the options. Nonqualified stock ...

Ip MS. Update on the current treatment of diabetic retinopathy. Presented at: American Academy of Ophthalmology meeting; Oct. 18-21, 2024; Chicago.